Project Description:

The construction of a new Biopharmaceutical Manufacturing Facility to the existing BMS Pharmaceutical Campus. Stewart is involved with the warehouse envelope of this project.
The Cruiserath site is a 45 Acre development on a 100 Acre site that is designed as a flexible, multi-purpose high containment (Band 4) highly-automated bulk production pharmaceutical facility.

Client: Bristol-Myers Squibb

Architect: Jacobs Eng. Ire Ltd

QS: Jacobs Eng. Ire Ltd

Size: circa 2800 sq.m

Value: circa € 8 million

Duration: 8 months

Back to Projects